Myotoxicity induced by an acidic Asp-49 phospholipase A2 isolated from Lachesis muta snake venom: Comparison with lysophosphatidylcholine

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 10, 2003, Pages 1470-1481

  Fuly, André L ^a   Calil Elias, Sabrina ^a   Martinez, Ana Maria B ^a   Melo, Paulo A ^a   Guimarães, Jorge A ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Asp 49 PLA2; Lachesis muta venom; Lysophosphatidylcholine; Myotoxicity; Phospholipase A2

Indexed keywords

4 BROMOPHENACYL BROMIDE; ACETIC ANHYDRIDE; CREATINE KINASE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; SNAKE VENOM;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME ISOLATION; ENZYME RELEASE; EXTENSOR DIGITORUM LONGUS MUSCLE; HISTOLOGY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LETHALITY; MOUSE; MUSCLE INJURY; MUSCLE NECROSIS; MUSCLE TOXICITY; NONHUMAN; PROTEIN FUNCTION; SNAKE;

LACHESIS MUTA; SERPENTES;

EID: 0038344789     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00129-8     Document Type: Article

References (46)

1. Calderon L., Lomonte B. Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129. Toxicon. 37:1999;683-687.
2. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon. 36:1998;1861-1869.
3. 2. The Biochemical Journal. 366:2002;971-976.
4. Chun J. Lysophospholipid receptors: Implication for neural signaling. Critical Reviews in Neurobiology. 13:1999;151-168.
5. 2-homologue from Bothrops pirajai venom. Toxicon. 36:1998;1395-1406.
6. 2, affects its pharmacological activities. Toxicon. 31:1993;1202-1206.
7. 2 isolated from Bothrops asper and Bothrops godmani snake venoms: Effects on enzymatic and pharmacological properties. Toxicon. 35:1997;241-252.
8. Evans J., Ownby C.L. Neutralization of edema, hemorrhage and myonecrosis induced by North American crotalid venoms in simulated first-aid treatments. Toxicon. 37:1999;633-650.
9. Exton J.H. Signaling through phosphatidylcholine breakdown. The Journal of Biological Chemistry. 265:1990;1-4.
10. Exton J.H. Phosphatidylcholine breakdown and signal transduction. Biochimica et Biophysica Acta. 1212:1994;26-42.
11. 2 myotoxins lyse cell cultures by two distinct mechanisms. Toxicon. 36:1998;1549-1555.
12. 2. Archives of Biochemistry and Biophysics. 284:1991;352-359.
13. 2 isolated from Lachesis muta snake venom. Toxicon. 38:2000;961-972.
14. 2 isoenzyme isolated from Lachesis muta snake venom. Biochemical Pharmacology. 63:2002;1589-1597.
15. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thrombosis Haemostatis. 78:1997;1372-1380.
16. 2 enzymes: Structure, function and mechanism (pp. 321-352). Wiley: Chichester.
17. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. The Journal of Cell Biology. 135:1996;1071-1083.
18. 2 from the venom of the cottonmouth snake at 2.0-Å resolution. The Journal of Biological Chemistry. 265:1990;17649-17656.
19. Kaiser I.I., Gutierrez J.M., Plummer D., Aird S.D., Odell G.V. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Archives of Biochemistry and Biophysics. 278:1990;319-325.
20. 2 enzymes: Structure, function and mechanism (pp. 1-28). Wiley: Chichester.
21. Kini R.M., Evans H.J. A model to explain the pharmacological effects of snake venom phospholipases. Toxicon. 27:1989;613-635.
22. Kondo H., Kondo S., Ikezawa H., Murata R., Ohsaka A. Studies on the quantitative methods for determination of hemorrhagic activity of Habu snake venom. Japanese Journal of Medical Sciences and Biology. 13:1960;43-51.
23. 2 homologues: Dissociation between enzymatic and biological activities. European Journal of Pharmacology. 343:1998;257-263.
24. 2 homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide. Biochemical Pharmacology. 59:2000;1289-1294.
25. 2. The Journal of Biological Chemistry. 261:1986;4797-4804.
26. Masamune A., Sakai Y., Satoh A., Fujita M., Yoshida M., Shimosegawa T. Lysophosphatidylcholine induces apoptosis in AR42J cells. Pancreas. 22:2001;75-83.
27. Masamune A., Sakai Y., Yoshida M., Satoh A., Satoh K., Shimosegawa T. Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells. Digestive Diseases and Sciences. 46:2001;1871-1881.
28. Mebs D., Ownby C.L. Myotoxic components of snake venoms: Their biochemical and biological activities. Pharmacological Therapy. 48:1990;223-236.
29. 2 myotoxins. Toxicon. 37:1999;199-215.
30. Melo P.A., Suarez-Kurtz G. Release of creatine kinase from skeletal muscles by Bothrops venoms: Heparin potentiation of inhibition by antivenin. Brazilian Journal of Medicine and Biological Research. 21:1988a;545-548.
31. Melo P.A., Suarez-Kurtz G. Release of sarcoplasmic enzymes from skeletal muscle by Bothrops jararacussu venom: Antagonism by heparin and by the serum of South American marsupials. Toxicon. 26:1988b;87-95.
32. Moura-da-Silva A.M., Desmond H., Laing G., Theakston R.D.G. Isolation and comparison of myotoxins isolated from venoms of different species of Bothrops genus. Toxicon. 29:1991;713-723.
33. 2 from Agkistrodon piscivorus piscivorus snake venom: Synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon. 39:2001;1587-1594.
34. 2 proteins. Toxicon. 37:1999;411-445.
35. Prokazova N.V., Zvezdina N.D., Korotaeva A.A. Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Moscow). 63:1998;31-37.
36. 2 from the venom of Agkistridon piscivorus piscivorus. The Journal of Biological Chemistry. 267:1992;22645-22657.
37. 2 myotoxin from Agkistrodon contortrix laticinctus snake venom. Archives of Biochemistry and Biophysics. 326:1996;21-30.
38. 2 from Bothrops pirajai snake venom. Archives of Biochemistry and Biophysics. 387:2001;188-196.
39. Soares A.M., Rodrigues V.M., Homsi-Brandeburgo M.I., Toyama M.H., Lombardi F.R., Arni R.K., Giglio J.R. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (Caissaca) venom: Biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon. 36:1998;503-514.
40. Suarez-Kurtz G., Eastwood A.B. Release of sarcoplasmic enzymes from frog skeletal muscle. American Journal of Physiology. 241:1981;C98-C105.
41. Sugiyama S., Kugiyama K., Ogata N., Doi H., Ota Y., Ohgushi M., Matsumura T., Oka H., Yasue H. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arteriosclerosis, Thrombosis and Vascular Biology. 18:1998;568-576.
42. 2: Biological and membrane-disrupting activities in the absence of catalysis. The Biochemical Journal. 36:2002;89-96.
43. Weiner J.A., Hecht J.H., Chun J. Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. Journal of Comparative Neurology. 398:1998;587-598.
44. Yuan Y., Schoenwaelder S.M., Salem H.H., Jackson S.P. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. The Journal of Biological Chemistry. 271:1996;27090-27098.
45. 2 from Agkistrodon halys pallas at 2.13 Å resolution. Acta Crystallographica. Section D, Biological Crystallography. 54:1998;510-521.
46. 2 modified by p-bromo-phenacyl-bromide. Toxicon. 36:1998;875-886.